Class II
Terminated
CSF-HC Otic Insufflation Capsule, Sulfacetamide Sodium/Ciprofloxacin/Hydrocortisone/Amphotericin B Otic Powder, 50mg/ 30mg/ 25mg/ 5mg, 5 count bottle, Edge Pharma, LLC, 856 Hercules Dr., Colchester, V…
Why: CGMP Deviations
- Company
- Edge Pharma, LLC
Colchester, VT, United States - Reported
- Feb 2, 2022
- Recall started
- Dec 6, 2021
- Ended
- Jun 7, 2023
- Where sold
- nationwide
- Amount
- 440 cartons
- Full product description
- CSF-HC Otic Insufflation Capsule, Sulfacetamide Sodium/Ciprofloxacin/Hydrocortisone/Amphotericin B Otic Powder, 50mg/ 30mg/ 25mg/ 5mg, 5 count bottle, Edge Pharma, LLC, 856 Hercules Dr., Colchester, VT 05446, NDC 05446-1634-01
- Lots / codes affected
- 10-2021-05@9 01-01-2022 & 10-2021-28@4 01-26-2022
Class I: could cause serious harm or death. Class II: could cause temporary or treatable problems. Class III: unlikely to cause harm.